|
|
|
|
|
|
|
|
|
|
|
|
|
13.03.26 - 22:57
|
RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit (PR Newswire)
|
|
|
NEW YORK, March 13, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of REGENXBIO, Inc. (NASDAQ: RGNX) between February 9, 2022 and January 27, 2026, inclusive (the "Class Period"), of the important April 14, 2026 lead plaintiff......
|
|
|
|
|
|
|
|
|
|
|
13.03.26 - 22:30
|
Aktuelle Aktien-Empfehlungen: Daimler Truck, Fresenius, Qiagen & Co. (Sharedeals)
|
|
|
Die Analystenhäuser haben zum Wochenschluss eine Reihe neuer Kaufempfehlungen für internationale und deutsche Aktien veröffentlicht. Mehrere Research-Institute sehen in unterschiedlichen Branchen weiterhin signifikantes Kurspotenzial und bekräftigen ihre positiven Einschätzungen mit konkreten Kurszielen. Daimler Truck-Aktie Besonders optimistisch zeigt sich Jefferies für Daimler Truck. Das Research-Institut bestätigt seine Kaufempfehlung und sieht das Kursziel bei 48 Euro. Die […]
The post Aktuelle Aktien-Empfehlungen: Daimler Truck, Fresenius, Qiagen & Co. first appeared on sharedeals.de....
|
|
|
13.03.26 - 22:12
|
1 Growth Stock Set to Skyrocket in 2026 and Beyond (Fool)
|
|
|
Well Health Technologies continues to experience rapid growth, with rising profitability and cash flows set to take the stock higher.
The post 1 Growth Stock Set to Skyrocket in 2026 and Beyond appeared first on The Motley Fool Canada....
|
|
|
|
|
|
|
|
|
|
|
13.03.26 - 22:03
|
InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement (GlobeNewswire EN)
|
|
|
JENA, Germany, March 13, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it has received a written notice (the “Notice”), dated March 11, 2026, from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty (30) consecutive business days, the bid price for the Company's ordinary shares had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Rule”)....
|
|
|
|
|
|
|
|